Management of ESRD in patients with autosomal dominant polycystic kidney disease.
about
Current management of autosomal dominant polycystic kidney diseaseVascular complications in autosomal dominant polycystic kidney diseaseSpanish guidelines for the management of autosomal dominant polycystic kidney diseaseNovel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney diseaseMetabolomics in the study of kidney diseasesA painful inheritance-patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research.Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney diseaseBlood pressure and survival in long-term hemodialysis patients with and without polycystic kidney diseaseHealthcare resource consumption and cost of care among patients with polycystic kidney disease in Italy.End-Stage Kidney Failure in Oman: An Analysis of Registry Data with an Emphasis on Congenital and Inherited Renal Diseases.Maximal kidney length predicts need for native nephrectomy in ADPKD patients undergoing renal transplantation.Autosomal dominant polycystic kidney disease with ectopic unilateral multicystic dysplastic kidney.Renal replacement therapy in ADPKD patients: a 25-year survey based on the Catalan registry.Ouabain Enhances ADPKD Cell Apoptosis via the Intrinsic Pathway.Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963-2014).Renal transplantation in autosomal dominant polycystic kidney disease.How Does a Patient's Primary Renal Disease Impact Chronic Dialysis Management?: Patients with Autosomal Dominant Polycystic Kidney Disease.Embolization of renal arteries before transplantation in patients with polycystic kidney disease: a single institution long-term experience.
P2860
Q26784073-FCF097F8-DAF5-471A-BCB4-C80CAC31BCDDQ26799638-BE38A655-1086-4D21-9EC1-CCD8FD202935Q26863397-10AD57FB-704B-4223-8EFF-9C573B7BB2DFQ27011660-86D090CF-C2AF-4D84-B2B5-4FC5457AC07BQ30066455-E48F1B99-DDD4-4C00-87DE-1DD384289264Q30204911-3696A119-3713-41AA-9C52-869A4AD1427AQ30418571-0A3B229E-A656-41E1-95D7-31311EB9D154Q30429482-6C0D1859-002A-4AEC-842B-6F78D1DEFC33Q33627670-59B16BA6-9368-484D-8ED0-7095D7152840Q33823176-07A0631B-9A84-4411-BACD-483BE6FA7617Q34437930-D76EF71C-5C8D-4BD6-AA3E-9FC7FF3D2A52Q34588344-9B88BF5A-0825-40B8-82EB-7FE146FB7B87Q34978995-631D4C1E-1E74-44F5-BD1C-A877F80D64C8Q36723606-FF3FED9D-ACDE-450C-8F92-04612A786951Q37650894-D141E979-2768-407B-A7F1-52CDA1CEF0D3Q38220783-1062DFF9-1A25-4BBE-956F-A7A2C327AF1EQ38503184-59A703B5-54BA-4044-90C8-2BAAAB30DE60Q53502964-72F125A0-3446-4612-B0C9-EFA8C664946F
P2860
Management of ESRD in patients with autosomal dominant polycystic kidney disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Management of ESRD in patients with autosomal dominant polycystic kidney disease.
@ast
Management of ESRD in patients with autosomal dominant polycystic kidney disease.
@en
Management of ESRD in patients with autosomal dominant polycystic kidney disease.
@nl
type
label
Management of ESRD in patients with autosomal dominant polycystic kidney disease.
@ast
Management of ESRD in patients with autosomal dominant polycystic kidney disease.
@en
Management of ESRD in patients with autosomal dominant polycystic kidney disease.
@nl
prefLabel
Management of ESRD in patients with autosomal dominant polycystic kidney disease.
@ast
Management of ESRD in patients with autosomal dominant polycystic kidney disease.
@en
Management of ESRD in patients with autosomal dominant polycystic kidney disease.
@nl
P1476
Management of ESRD in patients with autosomal dominant polycystic kidney disease.
@en
P2093
Ahsan Alam
Ronald D Perrone
P304
P356
10.1053/J.ACKD.2009.12.006
P577
2010-03-01T00:00:00Z